Ikapharmindo Putramas Tbk. (JK:IKPM) — Stock Price

Rp200.00 IDR
▲ 1.01% today

Ikapharmindo Putramas Tbk. (JK:IKPM) is currently trading at Rp200.00 IDR, up 1.01% today. Over the past 52 weeks, shares have ranged between Rp171.00 and Rp280.00. This page tracks Ikapharmindo Putramas Tbk.'s live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Ikapharmindo Putramas Tbk..

Ikapharmindo Putramas Tbk. (IKPM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Ikapharmindo Putramas Tbk.'s daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.

Ikapharmindo Putramas Tbk. Income Statement — Revenue, Profit & Earnings by Year

Ikapharmindo Putramas Tbk.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 202420232022
Total Revenue Rp412.07 Billion Rp441.14 Billion Rp398.73 Billion
Cost of Revenue Rp225.38 Billion Rp251.73 Billion Rp217.45 Billion
Gross Profit Rp186.69 Billion Rp189.41 Billion Rp181.28 Billion
Research & Development
SG&A Rp167.18 Billion Rp155.59 Billion Rp145.75 Billion
Total Operating Expenses
Operating Income Rp18.78 Billion Rp32.04 Billion Rp34.31 Billion
EBITDA
EBIT
Interest Expense Rp684.62 Million Rp369.61 Million Rp805.00 Million
Income Before Tax Rp8.03 Billion Rp20.78 Billion Rp22.72 Billion
Income Tax Expense
Net Income Rp5.01 Billion Rp15.34 Billion Rp16.58 Billion

Ikapharmindo Putramas Tbk. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Ikapharmindo Putramas Tbk.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 202420232022
Total Assets Rp491.38 Billion Rp463.38 Billion Rp387.55 Billion
Total Current Assets Rp337.20 Billion Rp308.08 Billion Rp268.80 Billion
Cash & Equivalents
Short-term Investments
Net Receivables Rp256.36 Billion Rp200.36 Billion Rp170.73 Billion
Inventory Rp51.76 Billion Rp56.01 Billion Rp79.28 Billion
Property, Plant & Equipment Rp108.92 Billion Rp113.50 Billion Rp78.21 Billion
Goodwill
Total Liabilities Rp245.25 Billion Rp218.67 Billion Rp210.85 Billion
Total Current Liabilities Rp220.76 Billion Rp196.17 Billion Rp193.46 Billion
Long-term Debt Rp0.00 Rp0.00
Net Debt
Total Stockholder Equity Rp246.12 Billion Rp244.71 Billion Rp176.70 Billion
Retained Earnings Rp45.59 Billion Rp44.36 Billion Rp63.80 Billion

Ikapharmindo Putramas Tbk. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Ikapharmindo Putramas Tbk. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 202420232022
Operating Cash Flow Rp-33.68 Billion Rp25.94 Billion Rp3.75 Billion
Capital Expenditures Rp3.65 Billion Rp45.18 Billion Rp4.86 Billion
Free Cash Flow
Investing Cash Flow Rp-2.99 Billion Rp-44.54 Billion Rp-4.83 Billion
Financing Cash Flow Rp16.21 Billion Rp52.01 Billion Rp-2.35 Billion
Dividends Paid Rp3.79 Billion Rp0.00
Stock-Based Compensation
Depreciation
Change in Cash Rp-20.46 Billion Rp33.41 Billion Rp-3.43 Billion

Ikapharmindo Putramas Tbk. Earnings History — EPS Actual vs. Analyst Estimates

Track Ikapharmindo Putramas Tbk.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Ikapharmindo Putramas Tbk..